Atlas Trials

MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer

Clinical trial NCT05233982 · UNKNOWN

Trial details

NCT number
NCT05233982
Sponsor
National Cancer Institute, Naples
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2021-12-09
Primary completion
2026-01-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.